# An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

> **NCT01508130** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 672 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01508130
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-31
- **Primary completion:** 2014-03-31
- **Final completion:** 2014-03-31
- **Target enrollment:** 672 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508130, "An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01508130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*